Arie Mayer's Insider Trades & SAST Disclosures

Arie Mayer's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.

Share

Note

This is a custom search result for pattern Arie Mayer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2025	30,000	126,134 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2025	6,975	133,109 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2024	30,000	86,809 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2024	9,325	96,134 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Apr 2023	30,000	56,809 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Purchase of securities on an exchange or from another person at price $ 2.22 per share.	03 Apr 2023	5,009	23,009 (0%)	0%	2.2	11,120	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Purchase of securities on an exchange or from another person at price $ 2.21 per share.	03 Apr 2023	3,800	26,809 (0%)	0%	2.2	8,398	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jul 2022	12,000	18,000 (0%)	0%		-	Common Stock
Oramed Pharmaceuticals Inc	Arie Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	6,000	6,000 (0%)	0%		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades